Zheng Quan Ri Bao
Search documents
初灵信息:截至1月20日,公司股东户数约为4.53万户
Zheng Quan Ri Bao· 2026-02-10 13:37
Group 1 - The core point of the article is that Chuling Information has approximately 45,300 shareholders as of January 20 [2]
炬光科技:公司正在持续积极开拓国内外消费电子等应用领域的潜在客户
Zheng Quan Ri Bao· 2026-02-10 13:37
(文章来源:证券日报) 证券日报网讯 2月10日,炬光科技在互动平台回答投资者提问时表示,公司正在持续积极开拓国内外消 费电子等应用领域的潜在客户,但目前尚未有量产项目。 ...
圣元环保:公司线上通过“媒体电商+社交媒体矩阵+传统媒体”等进行媒体营销
Zheng Quan Ri Bao· 2026-02-10 13:37
Core Viewpoint - Shengyuan Environmental Protection is actively expanding its brand presence through a combination of online and offline marketing strategies, achieving significant growth in store openings nationwide [2] Group 1: Marketing Strategies - The company utilizes a media marketing approach that includes "media e-commerce + social media matrix + traditional media" [2] - A brand MIS system and recruitment manual have been launched for offline marketing efforts [2] Group 2: Expansion and Growth - The company has signed contracts and opened over 20 stores across the country to date [2]
光大证券:公司充分发挥光大集团协同优势
Zheng Quan Ri Bao· 2026-02-10 13:37
(文章来源:证券日报) 证券日报网讯 2月10日,光大证券在互动平台回答投资者提问时表示,公司充分发挥光大集团协同优 势,坚持"以客户为中心"的发展理念,建设协同场景,挖掘协同资源,支持业务发展,以协同助力公司 强化服务实体经济和落实国家战略的力度和能力。 ...
赛分科技:聘任朱照锦先生为公司财务总监即财务负责人
Zheng Quan Ri Bao· 2026-02-10 13:37
证券日报网讯 2月10日,赛分科技发布公告称,公司董事会同意聘任朱照锦先生为公司财务总监即财务 负责人。 (文章来源:证券日报) ...
金牛化工:截至2025年9月30日,公司股东数为51662户
Zheng Quan Ri Bao· 2026-02-10 13:37
证券日报网讯 2月10日,金牛化工在互动平台回答投资者提问时表示,截至2025年9月30日,公司股东 人数为51662户。 (文章来源:证券日报) ...
云路股份:非晶产品产能利用率持续处于较高水平
Zheng Quan Ri Bao· 2026-02-10 13:37
Group 1 - The core viewpoint of the article highlights that Yunlu Co., Ltd. emphasizes the close relationship between its amorphous product business and the global distribution transformer industry development [2] - The company reports that its amorphous product capacity utilization rate has remained at a high level in recent years [2]
科德数控:公司坚持“价值竞争”而非单纯“价格竞争”
Zheng Quan Ri Bao· 2026-02-10 13:37
Core Viewpoint - The company emphasizes "value competition" over mere "price competition," focusing on high-end and economical product lines to balance short-term market competition with long-term development needs [2] Group 1: Company Strategy - The company implements a dual-track strategy with high-end and economical product models to enhance market competitiveness while maintaining quality [2] - The core competitive advantages lie in equipment reliability and precision retention, which are critical hard indicators for the company's offerings [2] - Cost reduction is achieved through optimized design without compromising quality, ensuring sustainable growth [2] Group 2: Market Perspective - The company believes that the market will eventually return to rationality, where only technically proficient enterprises can sustain long-term development [2] - Strengthening after-sales service and technical support is a key strategy to enhance customer loyalty and retention [2]
武商集团:当前公司经营保持平稳
Zheng Quan Ri Bao· 2026-02-10 13:37
证券日报网讯 2月10日,武商集团在互动平台回答投资者提问时表示,公司暂未收到证监会就相关经营 与市场表现事项的问询或调查通知,当前公司经营保持平稳,财务指标符合上市规则要求,未触及退市 风险警示情形。公司第一大股东持续秉持对股东及市场高度负责的态度,严格遵守法律法规及国资监管 要求,稳步推进公司治理和业务发展,全力维护公司价值和股东权益。公司将持续关注市场动态,不断 提升治理水平和经营质量,努力为股东创造长期价值。 (文章来源:证券日报) ...
均瑶健康:公司采用“自主菌株突破+产学研协同深化+产能同步落地”的三位一体研发策略
Zheng Quan Ri Bao· 2026-02-10 13:37
Core Viewpoint - Junyao Health adopts a three-pronged R&D strategy focusing on "independent strain breakthroughs, collaborative research with academia, and synchronized capacity implementation" to enhance its probiotic product matrix and maintain a competitive edge in technology [2] Group 1: R&D Strategy - The company emphasizes core strain independent research to establish technological barriers, particularly in fermentation technology and strain selection [2] - Junyao Health collaborates with universities and research institutions to build joint laboratories, accelerating the transformation of cutting-edge research results [2] - The company is committed to evidence-based research, aiming to catch up with international leading levels and closely integrating R&D outcomes with large-scale production capacity [2] Group 2: Production and Sales - The company enhances production efficiency through intelligent manufacturing processes, improving technical parameters [2] - Junyao Health has completed multiple outsourced R&D projects and patent applications, contributing to its comprehensive industry chain from R&D to production and sales [2] - The integration of technology innovation supports the enrichment and upgrading of the probiotic product matrix, forming a complete closed-loop industry chain [2]